rawfin.tv
Regencell Bioscience Faces Class Action Lawsuit
RegulationstocksAI Generated

Regencell Bioscience Faces Class Action Lawsuit

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Regencell Bioscience Holdings Ltd. (RGC) is facing a class action lawsuit filed by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges potential misconduct, prompting an investor alert.

RGCClass ActionLegal RiskBiotechnologyRegulation

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks